Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

AstraZeneca PLC (AZN)

51.33   0.82 (1.62%) 01-17 16:00
Open: 51.44 Pre. Close: 50.51
High: 51.55 Low: 51.16
Volume: 2,662,133 Market Cap: 134011M
AstraZeneca PLC belongs to the healthcare sector. The company develops and markets pharmaceutical products for various therapeutic classes such as gastrointestinal, cardiovascular, respiratory, cancer, immunology, and neuroscience.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 51.588 - 51.832 51.832 - 52.062
Low: 50.521 - 50.808 50.808 - 51.078
Close: 50.866 - 51.31 51.31 - 51.727

Technical analysis

as of: 2020-01-17 4:34:12 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 60.21     One year: 70.33
Support: Support1: 49.20    Support2: 47.74
Resistance: Resistance1: 51.55    Resistance2: 60.21
Pivot: 50.21
Moving Average: MA(5): 50.50     MA(20): 50.16
MA(100): 46.81     MA(250): 42.97
MACD: MACD(12,26): 0.54     Signal(9): 0.51
Stochastic oscillator: %K(14,3): 79.79     %D(3): 65.95
RSI: RSI(14): 66.67
52-week: High: 51.55  Low: 35.30  Change(%): 41.5
Average Vol(K): 3-Month: 285218  10-Days: 224184

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
AZN has closed above the upper band by 17.5%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 48.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to AZN's normal range. The bands have been in this narrow range for 8 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Azerbaijani currency rates for Jan. 17
Official exchange rate of the US dollar and euro against Azerbaijani manat is set at 1.7 and 1.8924 manat respectively

AstraZeneca’s Loss is Amarin Stock’s Big Gain This Year
AstraZeneca is stopping a large clinical study of its fish-oil-derived heart drug, Epanova. That’s good news for Amarin and AMRN stock.

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 2620.00
Shares Float (M) 2620.00
% Held by Insiders
% Held by Institutions 18.73
Shares Short (K) 7740
Shares Short P. Month (K)

Stock Financials

EPS 0.800
Book Value (p.s.) 4.640
PEG Ratio 1.59
Profit Margin 8.52
Operating Margin 6.09
Return on Assets (ttm) 1.5
Return on Equity (ttm) 14.4
Qtrly Rev. Growth 20.0
Gross Profit (p.s.) 6.714
Sales Per Share
EBITDA (p.s.) 1.615
Qtrly Earnings Growth -30.60
Operating Cash Flow (M) 3820.00
Levered Free Cash Flow (M) 5830.00

Stock Valuations

P/E 64.16
P/E Growth Ratio 0.02
P/BV 11.06
P/S 5.48
P/CF 35.21

Dividends & Splits

Dividend 2.800
Dividend Yield 0.05
Dividend Pay Date 2019-09-09
Ex-Dividend Date 2019-08-08
Forward Dividend 1.400
Last Split Date 2015-07-27
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.